C

씨유메디칼

115480KOSDAQ의료용 기기 제조업

47.5 / 100

Reference Date: 2026-04-13

Financial Score16.0 / 40
News Sentiment12.5 / 25
Momentum9.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Slightly up 1.1% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

CY Medikal focuses on emergency medical devices (AEDs) and surgical robotics, leveraging global AED market growth and partnerships with Chinese robotics firms to diversify revenue. In 2024, AEDs accounted for 86.2% of sales, with overseas expansion driven by subsidiaries in Germany and Japan.

Number of Employees

113people

Average Salary

52.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
38.00Industry Average 26.523.0Point

Higher than industry avg (caution)

PBR
0.54Industry Average 1.707.0Point

Half of industry avg (excellent)

ROE
1.38Industry Average 8.001.0Point

Well below industry avg

Debt Ratio
50.76Industry Average 10.950.0Point

4.6x industry avg (risky)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲7.9% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲48.3% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -6.2% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (36%)

Current 532Won52-week high 64452-week low 469
1-month return3.0Point

1m 1.14% (flat)

Volume trend3.0Point

Volume flat

Detailed Disclosure

9 totalPositive 0Neutral 9Negative 0
  • Neutral[기재정정]주식등의대량보유상황보고서(약식)2026-04-07
  • Neutral주식등의대량보유상황보고서(약식)2026-04-06
  • Neutral증권발행결과(자율공시)2026-03-30
  • Neutral정기주주총회결과2026-03-26
  • Neutral사업보고서 (2025.12)2026-03-19